FDA: Heart Bypass Drug May Be Risky

Save

A | A | A

(October 25, 2007)--A drug made by Bayer to prevent excessive bleeding during heart bypass surgery may carry a higher risk of death than other medications.

That finding by the Food and Drug Administration came as a Canadian study comparing the safety and efficacy of Trasylol with two others was halted.

Preliminary results from that trial also suggested the drug increased the risk of death when compared with the other drugs.

Bayer says it believes Trasylol remains a safe and effective treatment option.

Still, it says it will work to re-evaluate the drug's risks and benefits and determine where any label changes are needed.

Click Here For FDA Web Site

More Local And State News >>More National News >>More Business News >>Sports >> Weather >>

Save some money! Save a tree! Click here to get your morning news delivered directly to your email

More Stories
Swine Flu Claims Life Of Temple Woman

Flu Vaccinations Expected To Be Ready This Fall

Labels Recommended For Bottled Water

Government Tightens Food Safety Standards

Children Of Troops Sought Mental Health Care 2 Million Times Last Year

Thirty-Four More Cases Of Swine Flu Confirmed In Central Texas

Internet Therapy May Do The Trick For Insomnia Sufferers

Final Rules Out For Government Stem Cell Research

	Double Dollar Deals Half Price Deals at Central Texas restaurants and businesses. A new deal every Thursday at 7:00am.
	Boss of the Month Who is Central Texas’ best boss? Nominate your supervisor for Boss of the Month!
	Golden Apple Your chance to nominate an outstanding teacher. Find out how they are making a difference in classrooms.
	Emily Wants to Know Emily Matthews' inquisitive look at life in Central Texas.
	10 On Your Side Answers from our experts on topics that affect YOU.